OKYO OKYO Pharma Limited

NASDAQ
$1.34

OKYO Pharma Limited (OKYO) SEC Filings

Everything OKYO has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

22 filings
Date Form Filing
6-K Investor Presentation
6-K Other Reg Fd
6-K Investor Presentation
4/A
4/A
4/A
4/A
4/A
4/A
4/A
4
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.